Login / Signup

Prophylactic Chemotherapy with Methotrexate Leucovorin in High-Risk Hydatidiform Mole.

Soheila AminimoghaddamFatemeh MahmoudzadehMarzieh Mohammadi
Published in: Asian Pacific journal of cancer prevention : APJCP (2020)
This study concludes that prophylactic chemotherapy with MTX and leucovorin may be capable of reducing GTN, which supports the prescription of MTX in high-risk mole, especially in countries with limited resources. The toxicity of methotrexate can be reduced with the addition of leucovorin.<br />.
Keyphrases
  • high dose
  • locally advanced
  • squamous cell carcinoma
  • low dose